Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ADTRAN Holdings Inc | QH9 | May 31, 2024 | 5.03 | -2.37 |
AIXTRON SE | AIXA | May 31, 2024 | 20.94 | -2.88 |
ATOSS Software SE | AOF | May 31, 2024 | 232.50 | +0.87 |
Bechtle AG | BC8 | May 31, 2024 | 44.64 | -2.45 |
Cancom SE | COK | May 31, 2024 | 30.80 | +0.72 |
Carl Zeiss Meditec A G | AFX | May 31, 2024 | 84.65 | -5.37 |
Cdax-Gesamtindex (Perf) | CDAX | May 31, 2024 | 1 598.73 | +0.10 |
CompuGroup Medical SE & Co KgaA | COP | May 31, 2024 | 27.70 | +1.17 |
Dax (Performanceindex) | DAX | May 31, 2024 | 18 498.00 | +0.01 |
Deutsche Telekom AG | DTE | May 31, 2024 | 22.29 | +1.27 |
Energiekontor AG | EKT | May 31, 2024 | 71.90 | +1.99 |
Evotec SE | EVT | May 31, 2024 | 8.65 | +3.04 |
Freenet AG | FNTN | May 31, 2024 | 23.98 | +1.18 |
Hensoldt AG | HAG | May 31, 2024 | 37.36 | +1.52 |
Infineon Technologies AG | IFX | May 31, 2024 | 36.83 | -0.70 |
Jenoptik AG | JEN | May 31, 2024 | 27.38 | +0.74 |
Kontron AG. | KTN | May 31, 2024 | 21.72 | -0.28 |
Mdax (Performanceindex) | MDAX | May 31, 2024 | 26 717.00 | -0.33 |
Morphosys AG | MOR | May 31, 2024 | 68.65 | +0.88 |
Nagarro SE | NA9 | May 31, 2024 | 80.40 | -0.31 |
Nemetschek SE | NEM | May 31, 2024 | 83.55 | -1.94 |
Nordex SE | NDX1 | May 31, 2024 | 14.42 | -1.44 |
PNE AG | PNE3 | May 31, 2024 | 14.92 | +0.81 |
QIAGEN NV | QIA | May 31, 2024 | 39.37 | +0.24 |
Sap SE | SAP | May 31, 2024 | 165.96 | -1.55 |
Sartorius AG PRF PERPETUAL EUR | SRT3 | May 31, 2024 | 241.50 | +0.17 |
Sdax (Performance-Index) | SDXP | May 31, 2024 | 15 123.00 | +0.23 |
Siemens Healthineers AG | SHL | May 31, 2024 | 53.38 | -0.15 |
Siltronic AG | WAF | May 31, 2024 | 74.60 | -0.67 |
SMA Solar Technology AG | S92 | May 31, 2024 | 48.18 | -4.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.